ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

UPMC and Pitt announce $200 million for immunotherapy research and new collaboration center – NEXTpittsburgh

Continue reading

2018-02-14 Michael Zand NEWS

In effort to treat rare blinding disease, researchers turn stem cells into blood vessels – Science Daily


NEXTpittsburgh

UPMC and Pitt announce $200 million for immunotherapy research and new collaboration center
NEXTpittsburgh
Work will soon begin on a 200,000-square-foot building on the border of Shadyside and Bloomfield where some of Pittsburgh’s biggest names in medicine and engineering aim to make huge strides in immunotherapy. “Two of Pittsburgh’s research powerhouses …
Trib editorial: UPMC-Pitt immunotherapy center advances city’s medical legacyTribune-Review
Immunology Research Center Planned For Site Of Old Auto Plant On Baum Boulevard90.5 WESA

all 8 news articles »

Continue reading

2018-02-14 Michael Zand NEWS

IRB Barcelona paves the way to the use of immunotherapy to treat aggressive colon tumors – EurekAlert (press release)

EurekAlert (press release)IRB Barcelona paves the way to the use of immunotherapy to treat aggressive colon tumorsEurekAlert (press release)In a short space of time, immunotherapy, that is to say therapies based on stimulating the immune system against… Continue reading

2018-02-14 Michael Zand NEWS

Cellectis to license recently-granted CRISPR patents – Life Sciences Intellectual Property Review


Science Daily

In effort to treat rare blinding disease, researchers turn stem cells into blood vessels
Science Daily
Now, in a study published February 13 in Science Signaling, Lin’s team discovered that a chemical compound that activates ATF6 also converts patient-derived stem cells into blood vessels. “We wanted to see if there was a way to correct this gene defect …

Continue reading

2018-02-14 Michael Zand NEWS

Astellas Buys Stem Cell Gene-Editing Firm for $102.5M – Xconomy


Life Sciences Intellectual Property Review

Cellectis to license recently-granted CRISPR patents
Life Sciences Intellectual Property Review
Both patents centre on the use of CRISPR technology in T cells and “claim methods by which T cells are gene edited using transient expression of CRISPR/Cas9 components”, according to the release. Last year, Cellectis was granted European patent number …
Rupert BealeLondon Review of Books
America May Fall Behind in Genetic Technologies, and That’s OKChristian Post

all 5 news articles »

Continue reading

2018-02-14 Michael Zand NEWS

Efficacy Offsets High Costs for Immunotherapy in US, But Not Overseas – Curetoday.com

Efficacy Offsets High Costs for Immunotherapy in US, But Not OverseasCuretoday.comResearchers from Israel, the United Kingdom (UK) and Canada sought to determine the cost-effectiveness of Keytruda for the second-line treatment of patients with advanced… Continue reading

2018-02-14 Michael Zand NEWS

Synthetic Biology Market : Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And … – Digital Journal

Synthetic Biology Market : Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And …Digital JournalSynthetic Biology term refers the both the design and construction of biological components and entire novel biological sy… Continue reading

2018-02-14 Michael Zand NEWS

ASCO, NCCN release guidelines on managing immunotherapy toxicity – Healio

PR Newswire (press release)ASCO, NCCN release guidelines on managing immunotherapy toxicityHealio“Despite the often-durable clinical benefits of the immune checkpoint blockade therapy, [immune checkpoint inhibitor] use is associated with a spectrum of … Continue reading

2018-02-14 Michael Zand NEWS
  • 1
  • …
  • 528
  • 529
  • 530
  • 531
  • 532
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Xconomy

Astellas Buys Stem Cell Gene-Editing Firm for $102.5M
Xconomy
Universal Cells’ technology aims to make stem cells that don’t have some of the problems that current cell therapies face, such as the immune rejection of transplanted cells. This is an attractive prospect for Astellas, which has been working to get …
Astellas pledges $102.5M for universal donor cell companyFierceBiotech
Astellas Acquires Universal Cells, Inc.Markets Insider
Astellas upgrades Universal Cells licensing deal to a buyThe Pharma Letter
DEALSTREETASIA
all 6 news articles »